|
시장보고서
상품코드
2075910
불활성화 소아마비 및 광견병 백신 시장 : 백신 유형별, 불활성화 방법별, 연령층별, 유통 채널별, 지역별Inactivated Polio And Rabies Vaccines Market, by Vaccine, By Method of Inactivation, By Age Group, by Distribution Channel and by Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
불활성화 소아마비 및 광견병 백신 시장은 2026년에 13억 6,200만 달러 규모에 이를 것으로 추정되며, 2033년까지 19억 9,450만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 5.6%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 13억 6,200만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) : | 5.60% | 시장 규모 예측(2033년) : | 19억 9,450만 달러 |
비활성화 소아마비 바이러스(IPV) 1형, 2형, 3형으로 구성되어 있으며, 소아마비에 대한 능동 면역 작용을 갖는 백신입니다. 근육 내 접종을 통해 불활성화 소아마비 바이러스 백신(IPV)은 면역계를 활성화시켜 소아마비 바이러스에 대한 항체를 생성하게 합니다. 광견병 백신은 광견병을 예방하기 위해 사용되는 백신입니다. 안전하고 효과적인 광견병 백신이 시중에 많이 판매되고 있습니다. 이 약들은 일반적으로 개의 물림이나 박쥐의 물림으로 인해 광견병 바이러스에 노출되기 전, 그리고 노출 후 일정 기간 동안 광견병을 예방하기 위해 사용할 수 있습니다. 전 세계 각국 정부는 소아마비 근절을 위해 적극적으로 노력하고 있으며, 이로 인해 IPV 수요가 증가하고 있습니다. 또한, 북미 등 특정 지역에서 소아마비 발생률이 증가하고 있는 점도 이 부문의 성장에 기여하고 있습니다. 소아마비 및 광견병 발생률 증가가 불활성화 소아마비 및 광견병 백신 수요를 견인하고 있으며, 이로 인해 세계 불활성화 소아마비 및 광견병 백신 시장의 성장이 촉진될 것으로 예측됩니다.
시장 역학
시장 참여자들의 연구 개발 활동은 예측 기간 동안 세계 불활성화 소아마비 및 광견병 백신 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2021년 3월, 미국의 생명공학 기업인 Ocugen Inc.는 광견병, 소아마비 및 코로나19 백신에 관한 긍정적인 초기 결과를 발표했습니다. 이 임상시험용 백신은 수십년동안 소아마비 백신 제조에 사용되어 온 것과 동일한 베로 세포 제조 플랫폼을 채택하고 있습니다.
본 조사의 주요 특징 :
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로, 세계 불활성화 소아마비 및 광견병 백신 시장의 주요 기업 프로파일을 소개했습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 책 '세계의 불활성화 소아마비 및 광견병 백신 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 불활성화 소아마비 및 광견병 백신 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 불활성화 소아마비 및 광견병 백신 시장 : 제품 유형별(2021-2033년)
제5장 세계의 불활성화 소아마비 및 광견병 백신 시장 : 불활성화 방법별(2021-2033년)
제6장 세계의 불활성화 소아마비 및 광견병 백신 시장 : 연령층별(2021-2033년)
제7장 세계의 불활성화 소아마비 및 광견병 백신 시장 : 유통 채널별(2021-2033년)
제8장 세계의 불활성화 소아마비 및 광견병 백신 시장 : 지역별(2021-2033년)
제9장 기업 개요
제10장 섹션
AJY 26.07.09Inactivated Polio And Rabies Vaccines Market is estimated to be valued at USD 1,362.0 Mn in 2026 and is expected to reach USD 1,994.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,362.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.60% | 2033 Value Projection: | USD 1,994.5 Mn |
A vaccine consisting of inactivated poliovirus (IPV) types 1, 2, and 3, with active immunizing activity against poliomyelitis. Upon intramuscular vaccination, inactivated poliovirus vaccine (IPV) activates the immune system to develop antibodies against polio viruses. The rabies vaccine is a vaccine used to prevent rabies. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies before, and, for some time, after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite. Governments around the world are actively working towards eradicating polio, which has led to increased demand for IPV. Additionally, the rising prevalence of polio in certain regions, such as the North America region, has also contributed to the growth of this segment. The increasing prevalence of polio and rabies diseases is driving the growth of the inactivated polio and the rabies vaccine associated with the virus is expected to boost the global inactivated polio and rabies vaccine market growth.
Market Dynamics
Research and development activity by market players is expected to spur the global inactivated polio and rabies vaccines market growth over the forecast period. For Instance, in March 2021, Ocugen Inc., is a biotech company in the U.S., announced positive top-line data for rabies, polio and COVID-19 Vaccine. Investigational vaccine that uses the same vero cell manufacturing platform that had been used in the production of polio vaccines for decades.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global inactivated polio and rabies vaccines market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Bharat Biotech., BIO-MED, Serum Institute of India Pvt. Ltd., Kedrion Biopharma Inc. GlaxoSmithKline plc., Bilthoven Biologicals, Merck & Co., Inc., Pfizer Inc, Cadila Healthcare Limited, Sanofi Pasteur India Pvt Ltd, Chiron Behring Vaccines Private Ltd ,Zoetis Inc., Elanco.,Boehringer Ingelheim International GmbH,Indian Immunologicals Ltd, Wyeth pharmaceuticals, Berna Biotech Ltd., Novartis Vaccines Ltd and Medimmune LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global inactivated polio and rabies vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inactivated polio and rabies vaccines market
Detailed Segmentation:
- Global Inactivated Polio And Rabies Vaccines Market, By Product Type:
- Inactivated Polio Vaccine
- Inactivated Rabies Vaccine
- Global Inactivated Polio And Rabies Vaccines Market, By Method of Inactivation (Revenue, USD Mn, 2021 - 2033)
- Radiation Method
- Heat Inactivation
- Solvent Detergent Method
- pH Concentration
- Health Activation
- Others
- Global Inactivated Polio And Rabies Vaccines Market, By Age Group (Revenue, USD Mn, 2021 - 2033)
- Pediatrics
- Adults
- Global Inactivated Polio And Rabies Vaccines Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Government
- Private
- Global Inactivated Polio And Rabies Vaccines Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Bharat Biotech.
- BIO-MED
- Serum Institute of India Pvt. Ltd.
- Kedrion Biopharma Inc.
- GlaxoSmithKline plc..
- Bilthoven Biologicals.
- Merck & Co.
- Pfizer Inc.
- Cadila Healthcare Limited
- Sanofi Pasteur India Pvt Ltd
- Chiron Behring Vaccines Private Ltd
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Indian Immunologicals Ltd
- Wyeth pharmaceuticals
- Berna Biotech Ltd.
- Novartis Vaccines Ltd
- Medimmune LLC.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product type
- Market Snapshot, By Method of Activation
- Market Snapshot, By Age Group
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Inactivated Polio and Rabies Vaccines Market, By Product Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Inactivated Polio Vaccine Introduction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Inactivated Rabies Vaccine Introduction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global Inactivated Polio and Rabies Vaccines Market, By Method of Inactivation, 2021 - 2033 (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Solvent Detergent Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Radiation Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- pH Concentration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Heat Inactivation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
6. Global Inactivated Polio and Rabies Vaccines Market, By Age Group, 2021 - 2033 (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
7. Global Inactivated Polio and Rabies Vaccines Market, By Distribution Channel, 2021 - 2033 (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Government
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
8. Global Inactivated Polio and Rabies Vaccines Market, By Region, 2021 - 2033 (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- North America
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of Inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of Inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033 (US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Company Profiles
- Bharat Biotech
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- BIO-MED
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Serum Institute of India Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Kedrion Biopharma Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bilthoven Biologicals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Cadila Healthcare Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi Pasteur India Pvt Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Chiron Behring Vaccines Private Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Zoetis Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Elanco.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Boehringer Ingelheim International GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Indian Immunologicals Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Wyeth pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Berna Biotech Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Novartis Vaccines Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Medimmune LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
10. Section
- References
- Research Methodology
- About us and Sales Contact
